SARS-CoV-2 neutralizing antibody response after three doses of mRNA1273 vaccine and COVID-19 in hemodialysis patients

BACKGROUND: In hemodialysis patients, a third vaccination is frequently administered to augment protection against coronavirus disease 2019 (COVID-19). However, the newly emerged B.1.1.159 (Omicron) variant may evade vaccinal protection more easily than previous strains. It is of clinical interest t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoling, Han, Maggie, Fuentes, Lemuel Rivera, Thwin, Ohnmar, Grobe, Nadja, Wang, Kevin, Wang, Yuedong, Kotanko, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470295/
https://www.ncbi.nlm.nih.gov/pubmed/36106337
http://dx.doi.org/10.3389/fneph.2022.926635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470295/
https://www.ncbi.nlm.nih.gov/pubmed/36106337
http://dx.doi.org/10.3389/fneph.2022.926635

Ejemplares similares